Literature DB >> 26582558

Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition.

Christian Werner1, Martin Pauli2, Sören Doose3, Andreas Weishaupt4, Holger Haselmann5, Benedikt Grünewald5, Markus Sauer3, Manfred Heckmann2, Klaus V Toyka4, Esther Asan6, Claudia Sommer4, Christian Geis7.   

Abstract

Stiff-person syndrome is the prototype of a central nervous system disorder with autoantibodies targeting presynaptic antigens. Patients with paraneoplastic stiff-person syndrome may harbour autoantibodies to the BAR (Bin/Amphiphysin/Rvs) domain protein amphiphysin, which target its SH3 domain. These patients have neurophysiological signs of compromised central inhibition and respond to symptomatic treatment with medication enhancing GABAergic transmission. High frequency neurotransmission as observed in tonic GABAergic interneurons relies on fast exocytosis of neurotransmitters based on compensatory endocytosis. As amphiphysin is involved in clathrin-mediated endocytosis, patient autoantibodies are supposed to interfere with this function, leading to disinhibition by reduction of GABAergic neurotransmission. We here investigated the effects of human anti-amphiphysin autoantibodies on structural components of presynaptic boutons ex vivo and in vitro using electron microscopy and super-resolution direct stochastic optical reconstruction microscopy. Ultrastructural analysis of spinal cord presynaptic boutons was performed after in vivo intrathecal passive transfer of affinity-purified human anti-amphiphysin autoantibodies in rats and revealed signs of markedly disabled clathrin-mediated endocytosis. This was unmasked at high synaptic activity and characterized by a reduction of the presynaptic vesicle pool, clathrin coated intermediates, and endosome-like structures. Super-resolution microscopy of inhibitory GABAergic presynaptic boutons in primary neurons revealed that specific human anti-amphiphysin immunoglobulin G induced an increase of the essential vesicular protein synaptobrevin 2 and a reduction of synaptobrevin 7. This constellation suggests depletion of resting pool vesicles and trapping of releasable pool vesicular proteins at the plasma membrane. Similar effects were found in amphiphysin-deficient neurons from knockout mice. Application of specific patient antibodies did not show additional effects. Blocking alternative pathways of clathrin-independent endocytosis with brefeldin A reversed the autoantibody induced effects on molecular vesicle composition. Endophilin as an interaction partner of amphiphysin showed reduced clustering within presynaptic terminals. Collectively, these results point towards an autoantibody-induced structural disorganization in GABAergic synapses with profound changes in presynaptic vesicle pools, activation of alternative endocytic pathways, and potentially compensatory rearrangement of proteins involved in clathrin-mediated endocytosis. Our findings provide novel insights into synaptic pathomechanisms in a prototypic antibody-mediated central nervous system disease, which may serve as a proof-of-principle example in this evolving group of autoimmune disorders associated with autoantibodies to synaptic antigens.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  amphiphysin; autoantibody; clathrin-mediated endocytosis; dSTORM super-resolution microscopy; stiff-person syndrome

Mesh:

Substances:

Year:  2015        PMID: 26582558     DOI: 10.1093/brain/awv324

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  19 in total

Review 1.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 3.  NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture.

Authors:  Josep Dalmau
Journal:  Neurology       Date:  2016-12-06       Impact factor: 9.910

4.  'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?

Authors:  Sarosh R Irani
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

Review 5.  Stiff person syndrome spectrum disorders; more than meets the eye.

Authors:  Scott D Newsome; Tory Johnson
Journal:  J Neuroimmunol       Date:  2022-06-12       Impact factor: 3.221

Review 6.  Autoantibodies in neurological disease.

Authors:  Harald Prüss
Journal:  Nat Rev Immunol       Date:  2021-05-11       Impact factor: 53.106

Review 7.  Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.

Authors:  Farwa Ali; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.532

8.  Evolution, immunity and the emergence of brain superautoantigens.

Authors:  Serge Nataf
Journal:  F1000Res       Date:  2017-02-21

Review 9.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

Review 10.  Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.

Authors:  Katarzyna Lepeta; Mychael V Lourenco; Barbara C Schweitzer; Pamela V Martino Adami; Priyanjalee Banerjee; Silvina Catuara-Solarz; Mario de La Fuente Revenga; Alain Marc Guillem; Mouna Haidar; Omamuyovwi M Ijomone; Bettina Nadorp; Lin Qi; Nirma D Perera; Louise K Refsgaard; Kimberley M Reid; Mariam Sabbar; Arghyadip Sahoo; Natascha Schaefer; Rebecca K Sheean; Anna Suska; Rajkumar Verma; Cinzia Vicidomini; Dean Wright; Xing-Ding Zhang; Constanze Seidenbecher
Journal:  J Neurochem       Date:  2016-09-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.